Dec. 12, 2012 (China Knowledge) - Shanghai Fosun Pharmaceutical (Group) Co<600196>, the medical subsidiary of Fosun International Ltd<0656>, China's largest privately-owned conglomerate, has said it will issue RMB 500 million in super short-term bills with a maturity of 180 days on the interbank market on Dec. 18.
The company said that the bills will be issued at face value, and the coupon rate determined in the process of book-building.
Both value and payment due date is set on Dec. 19, and the to-be-issued bills tradable Dec. 20.
RMB 150 million of the proceeds from the issue will be used to replenish working capital, while the remaining RMB 350 million to repay bank loans, said the issuer.
Shanghai Brilliance Credit Rating & Investors Service Co Ltd has rated the issuer and bills AA+ and A-1, respectively.
Bank of Beijing Co Ltd <601169> has been assigned as lead underwriter and bookerrunner. China Zheshang Bank will be the joint lead underwriters for the offering.
This will be the issuer's first super short-term bills this year.